🇺🇸 FDA
Patent

US 12357697

Pharmaceutical compositions comprising bupropion and cysteine

granted A61KA61K31/137A61K31/198

Quick answer

US patent 12357697 (Pharmaceutical compositions comprising bupropion and cysteine) held by AXSOME THERAPEUTICS, INC. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/137, A61K31/198, A61K31/485, A61K47/542